Ind-Swift Laboratories
INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com

Stock Price vs Company Growth
1d
2.0%
1w
3.9%
1m
14.8%
3m
25.2%
6m
3.6%
1y
8.9%
5y
30.7%
10y
12.9%
all
4.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 102 2.0%
102
160
Company Overview

Sales
726 Cr
Growth: -19.2%
Profit after Tax
-127 Cr
Growth: 32.6%
Small Cap
602 Cr
P/E: 2.3x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 726
Growth -19.2%
EBITDA -1.0%
P/S 0.8x
Dividend 0.0%
P/E 2.3x
Book Value ₹ 158
PEG Ratio -0.1x
ROE -15.1%
P/B 0.6x
Shareholding Pattern

Institutions
Edelweiss India Special Situations Fund Ii
10.43 %
Ec Special Situations Fund
6.82 %
Ashokkumar Chandak
2.79 %
Eisaf Ii Onshore Fund
2.24 %
Sri Ganesh Biotech Private Limited
1.26 %
Promoters
Essix Biosciences Limited
21.71 %
Ind Swift Ltd
16.08 %
N.R. Munjal
1.56 %
Rishav Mehta
0.77 %
Himanshu Jain
0.69 %
Others
Increase    Decrease    No change
Company Profile Detailed

Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).
Investors (112)
Followers (1)